ACOR Annual Working Capital
-$152.98 M
-$197.14 M-446.38%
31 December 2023
Summary:
As of January 29, 2025, ACOR annual working capital is -$152.98 million, with the most recent change of -$197.14 million (-446.38%) on December 31, 2023. During the last 3 years, it has fallen by -$237.06 million (-281.94%).ACOR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACOR Quarterly Working Capital
-$175.48 M
-$22.50 M-14.71%
31 March 2024
Summary:
As of January 29, 2025, ACOR quarterly working capital is -$175.48 million, with the most recent change of -$22.50 million (-14.71%) on March 31, 2024. Over the past year, it has dropped by -$208.84 million (-626.11%).ACOR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACOR Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -446.4% | -626.1% |
| 3 y3 years | -281.9% | -409.7% |
| 5 y5 years | -139.4% | -154.7% |
ACOR Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -139.4% | -123.6% |
Acorda Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | -$175.48 M(+14.7%) |
| Dec 2023 | -$152.98 M(-446.4%) | -$152.98 M(-657.6%) |
| Sept 2023 | - | $27.43 M(-20.5%) |
| June 2023 | - | $34.53 M(+3.5%) |
| Mar 2023 | - | $33.35 M(-24.5%) |
| Dec 2022 | $44.16 M(-8.2%) | $44.16 M(+48.9%) |
| Sept 2022 | - | $29.67 M(-16.2%) |
| June 2022 | - | $35.40 M(+2.7%) |
| Mar 2022 | - | $34.45 M(-28.4%) |
| Dec 2021 | $48.13 M(-42.8%) | $48.13 M(+67.1%) |
| Sept 2021 | - | $28.80 M(-36.4%) |
| June 2021 | - | $45.29 M(-20.1%) |
| Mar 2021 | - | $56.67 M(-32.6%) |
| Dec 2020 | $84.08 M(-26.7%) | $84.08 M(+543.6%) |
| Sept 2020 | - | $13.06 M(-34.0%) |
| June 2020 | - | $19.79 M(-79.7%) |
| Mar 2020 | - | $97.66 M(-14.9%) |
| Dec 2019 | $114.73 M(-70.4%) | $114.73 M(-48.4%) |
| Sept 2019 | - | $222.34 M(-15.9%) |
| June 2019 | - | $264.42 M(-17.5%) |
| Mar 2019 | - | $320.62 M(-17.3%) |
| Dec 2018 | $387.85 M(+30.3%) | $387.85 M(-5.6%) |
| Sept 2018 | - | $410.89 M(+10.0%) |
| June 2018 | - | $373.68 M(+20.2%) |
| Mar 2018 | - | $310.83 M(+4.4%) |
| Dec 2017 | $297.74 M(+138.7%) | $297.74 M(+53.7%) |
| Sept 2017 | - | $193.68 M(+30.5%) |
| June 2017 | - | $148.47 M(+15.3%) |
| Mar 2017 | - | $128.82 M(+3.3%) |
| Dec 2016 | $124.76 M(-65.4%) | $124.76 M(+4.1%) |
| Sept 2016 | - | $119.83 M(-5.7%) |
| June 2016 | - | $127.04 M(-71.1%) |
| Mar 2016 | - | $439.28 M(+21.8%) |
| Dec 2015 | $360.73 M(+30.5%) | $360.73 M(+7.3%) |
| Sept 2015 | - | $336.33 M(+6.4%) |
| June 2015 | - | $315.96 M(+4.7%) |
| Mar 2015 | - | $301.67 M(+9.2%) |
| Dec 2014 | $276.33 M | $276.33 M(-62.8%) |
| Sept 2014 | - | $742.97 M(+24.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $598.52 M(+122.7%) |
| Mar 2014 | - | $268.71 M(-0.7%) |
| Dec 2013 | $270.69 M(+15.6%) | $270.69 M(-9.6%) |
| Sept 2013 | - | $299.55 M(-5.2%) |
| June 2013 | - | $316.05 M(+7.5%) |
| Mar 2013 | - | $294.01 M(+25.5%) |
| Dec 2012 | $234.19 M(-14.4%) | $234.19 M(+11.1%) |
| Sept 2012 | - | $210.79 M(-11.7%) |
| June 2012 | - | $238.80 M(-10.1%) |
| Mar 2012 | - | $265.66 M(-2.9%) |
| Dec 2011 | $273.60 M(+26.1%) | $273.60 M(+5.3%) |
| Sept 2011 | - | $259.94 M(+16.4%) |
| June 2011 | - | $223.28 M(+2.6%) |
| Mar 2011 | - | $217.61 M(+0.3%) |
| Dec 2010 | $216.92 M(-1.6%) | $216.92 M(+3.3%) |
| Sept 2010 | - | $210.06 M(+8.8%) |
| June 2010 | - | $193.01 M(-1.9%) |
| Mar 2010 | - | $196.83 M(-10.7%) |
| Dec 2009 | $220.38 M(+6.2%) | $220.38 M(-10.6%) |
| Sept 2009 | - | $246.43 M(-7.8%) |
| June 2009 | - | $267.34 M(+39.6%) |
| Mar 2009 | - | $191.51 M(-7.7%) |
| Dec 2008 | $207.44 M(+189.0%) | $207.44 M(-9.8%) |
| Sept 2008 | - | $229.95 M(+95.1%) |
| June 2008 | - | $117.86 M(-9.4%) |
| Mar 2008 | - | $130.07 M(+81.2%) |
| Dec 2007 | $71.77 M(+115.4%) | $71.77 M(-14.0%) |
| Sept 2007 | - | $83.44 M(+5.9%) |
| June 2007 | - | $78.82 M(+189.7%) |
| Mar 2007 | - | $27.21 M(-18.3%) |
| Dec 2006 | $33.32 M(-420.6%) | $33.32 M(+513.1%) |
| Sept 2006 | - | $5.43 M(-56.1%) |
| June 2006 | - | $12.38 M(-16.8%) |
| Mar 2006 | - | $14.89 M(-243.2%) |
| Dec 2005 | -$10.39 M(-214.6%) | -$10.39 M(-14.8%) |
| Sept 2005 | - | -$12.20 M(-125.9%) |
| Dec 2004 | $9.07 M(-77.8%) | - |
| Dec 2003 | $40.89 M(-30.7%) | - |
| Sept 2003 | - | $47.08 M |
| June 2003 | $58.98 M | - |
FAQ
- What is Acorda Therapeutics annual working capital?
- What is the all time high annual working capital for Acorda Therapeutics?
- What is Acorda Therapeutics annual working capital year-on-year change?
- What is Acorda Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Acorda Therapeutics?
- What is Acorda Therapeutics quarterly working capital year-on-year change?
What is Acorda Therapeutics annual working capital?
The current annual working capital of ACOR is -$152.98 M
What is the all time high annual working capital for Acorda Therapeutics?
Acorda Therapeutics all-time high annual working capital is $387.85 M
What is Acorda Therapeutics annual working capital year-on-year change?
Over the past year, ACOR annual working capital has changed by -$197.14 M (-446.38%)
What is Acorda Therapeutics quarterly working capital?
The current quarterly working capital of ACOR is -$175.48 M
What is the all time high quarterly working capital for Acorda Therapeutics?
Acorda Therapeutics all-time high quarterly working capital is $742.97 M
What is Acorda Therapeutics quarterly working capital year-on-year change?
Over the past year, ACOR quarterly working capital has changed by -$208.84 M (-626.11%)